🔗 Share this article

Grammy-winning soul vocalist D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The brilliant light of our family has faded away for us in this life,” his relatives stated. “After a lengthy and courageous battle with cancer, we are heartbroken to announce that D’Angelo, known to his fans around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his pioneering modern soul style and partnerships with renowned musicians.

He launched his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The album reached No. 4 on Billboard’s Top R&B Albums chart, earned platinum status soon after, and earned several award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his music career into the stratosphere. The record premiered at the top spot on both the R&B charts and the Billboard 200. He received two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a reluctant one, in the public consciousness. The personal depiction featured the artist, famously bare to his midsection, performing straight into the lens.

D’Angelo retreated from the spotlight after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe car crash that put him in critical condition.

More than a decade later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with another No. 1 debut on the R&B chart and a Grammy for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo made only a few public appearances in the subsequent period.

The musician was scheduled as a headliner for the 2025 music event, but his appearance was canceled, citing an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s well-being in the months before his death, he had apparently been hospitalized for months and in hospice for two weeks.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic malignancy, one of the most deadly and hardest to prevent types of the disease, on a gifted artist whose existence was ended too soon.

“We are saddened that he can only provide dear memories with his loved ones, but we are forever thankful for the legacy of extraordinarily moving songs he leaves behind,” his family said.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic cancer impacts the digestive organ, a small organ that produces the hormone insulin and is vital in breaking down food, among additional roles. The size and location of the organ in the human system make it more challenging to identify cancer.

Although this cancer makes up only approximately three percent of cancer diagnoses each year in the U.S., it is causes seven percent of cancer deaths.

Nearly seventy thousand people will be found to have this condition and about fifty-two thousand will die of the disease in 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have limited and poor treatment options, and a smaller window to make a meaningful impact on the well-being of patients,” noted a medical oncologist.

Because this disease rarely causes initial signs, it’s often identified only after the disease is advanced. Even when a patient has indicators they are often vague and may be confused with a several common illnesses.

“Currently, there is no effective method to identify pancreatic cancer in the initial phases, apart from listening to your body and speaking with your doctor if there are unfamiliar symptoms,” said a medical director.

Frequent indicators of pancreatic cancer encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s death is an outlier, as pancreatic cancer is most common in individuals in the 65 to 75 range. However, many cancers, including pancreatic cancer, have become increasingly prevalent in younger adults.

“This disease diagnosed before the age of 50 is deemed rare, yet concerningly, clinicians are noticing a growing number of younger patients affected by this condition,” commented a specialist.

Genetic Background Affects Cancer Risk

In the absence of reliable screening tools for pancreatic cancer, experts stressed the significance of knowing your family’s health background. Certain risk factors, such as tobacco use and excess weight also play a role in the onset of this disease.

Black individuals have the highest incidence of pancreatic cancer in the U.S. and are most likely to be diagnosed with untreatable disease.

“The first step toward reducing one’s chance of pancreatic cancer is assessing individual susceptibility. Individuals should review their genetic background, genetic background, and health issues, such as diabetes, long-term pancreas inflammation, or overweight that may raise their vulnerability,” said a specialist.

Hereditary elements are associated with as much as 10% of all pancreatic cancer cases. If a relative in your family has had pancreatic cancer, you may want to consider DNA analysis.

“For people with a family history of pancreatic cancer or those carrying high risk DNA changes, screening may involve advanced imaging such as MRI scans or internal ultrasound to find early changes in the pancreas,” he explained.

For those looking to lower their chance, habit adjustments may have an effect. The most effective step you can take to reduce your susceptibility of pancreatic cancer is to quit smoking, and if you are a non-smoker, avoid exposure altogether.

Heavy drinking is associated with pancreas inflammation, a contributing element for this malignancy, so reducing or avoiding alcohol may help lower your chance.

Controlling your weight or shedding pounds may also help reduce your risk. Individuals with obesity are 20% more likely to get pancreatic cancer. This malignancy also is more frequent in those with diabetes, and weight loss can also lower the risk of type 2 diabetes.

Despite pancreatic cancer’s grim outlook, there is still hope.

“We are making progress with treatments and newer combination chemotherapy. There are emerging targeted therapies that already are showing results,” remarked a expert.

For many people, however, education about this uncommon but {dev